The DTWD2 Knockout HeLa Polyclonal Cells represent a CRISPR/Cas9-edited polyclonal knockout cell population designed to disrupt the DTWD2 gene in the human HeLa cell line. This loss-of-function model is generated through target-gene disruption, providing a heterogeneous pool of edited cells suitable for functional genomics studies. The polyclonal format captures a range of editing outcomes across the population, enabling robust phenotypic analysis without clonal selection bias.
The host cell line, HeLa, is an immortalized epithelial cell line derived from a cervical adenocarcinoma and is positive for human papillomavirus type 18 (HPV18). Widely employed in biomedical research, HeLa cells offer a well-characterized system for cancer biology, signal transduction, and drug discovery studies. Their robust growth, ease of transfection, and extensive experimental history make them an ideal platform for generating knockout models.
The DTWD2 gene encodes an uncharacterized protein containing a DTW domain, a conserved motif found in a variety of proteins implicated in diverse cellular processes, including potential roles in RNA metabolism. Currently, the precise molecular function, upstream regulators, downstream targets, and interacting factors of DTWD2 remain unknown. The absence of defined pathway associations underscores the value of this knockout model as a discovery tool for delineating the protein’s biochemical activities and biological significance.
In the HeLa cellular context, loss of DTWD2 function may reveal previously unrecognized roles in cervical carcinoma biology or more general epithelial cell physiology. Given the HPV18-positive background, this model could help elucidate potential links between viral oncoproteins and DTW domain-containing proteins. The knockout cells provide a clean genetic background to assess effects on cell viability, migration, and transcriptomic profiles, contributing to a mechanistic understanding of DTWD2.
This polyclonal knockout product is optimized for a range of downstream applications, including functional characterization of DTWD2, investigation of DTW domain protein biology, and RNA metabolism research. Researchers can employ established assays such as Western blotting to confirm protein loss, RT-qPCR for transcript analysis, RNA-seq for global gene expression profiling, and functional assays to monitor cell viability and migration. For additional details and technical support, please contact Ascent Research.
